Furthermore, dual suppression by NVP-BEZ235 of both PI3K and mTORC1/2 signaling has been shown to lead to tumor regression in a genetically engineered mouse model for sporadic CRC [151]. The gene discussed is PIK3CA; the disease is neoplasm.